Mi. Forray et al., REGULATION OF ENDOGENOUS NORADRENALINE RELEASE FROM THE BED NUCLEUS OF STRIA TERMINALIS, Biochemical pharmacology, 49(5), 1995, pp. 687-692
The bed nucleus of stria terminalis (BNST) contains the highest concen
tration of noradrenaline (NA) in the brain. Minislices of the ventral
portion of the bed nucleus of stria terminalis (vBNST) were used to st
udy the release of endogenous NA. High K+ induced a Ca2+-dependent and
reserpine-sensitive release of NA. Clonidine (1 mu M), an alpha(2)-no
radrenergic receptor agonist, significantly decreased K+-induced relea
se of NA, whereas yohimbine (1 mu M), an alpha(2)-noradrenergic antago
nist, increased this release. N-Methyl-D-aspartate (NMDA), a specific
agonist of NMDA-type glutamate receptors. evoked the release of NA fro
m vBNST minislices. In the presence of D-serine (10 mu M), an agonist
at the glycine site associated with the NMDA receptor, the NMDA effect
was significantly higher. Glycine (1 mu M) also increased NA release
evoked by NMDA. However, glycine exhibited a significant effect by its
elf, suggesting the existence of strychnine-sensitive glycine receptor
s in vBNST. Endogenous NA release induced by 40 mM K+ and NMDA was not
additive. Thus, vBNST minislices seem to be a good model to study the
release of endogenous NA in the CNS. Such NA release in the vBNST is
regulated by alpha(2)-noradrenergic receptors and by glutamate through
NMDA receptors.